115 related articles for article (PubMed ID: 15134820)
1. Aldosterone-synthase overexpression in heart: a tool to explore aldosterone's effects.
Heymes C; Garnier A; Fuchs S; Bendall JK; Nehme J; Ambroisine ML; Robidel E; Swynghedauw B; Milliez P; Delcayre C
Mol Cell Endocrinol; 2004 Mar; 217(1-2):213-9. PubMed ID: 15134820
[TBL] [Abstract][Full Text] [Related]
2. Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice.
Garnier A; Bendall JK; Fuchs S; Escoubet B; Rochais F; Hoerter J; Nehme J; Ambroisine ML; De Angelis N; Morineau G; d'Estienne P; Fischmeister R; Heymes C; Pinet F; Delcayre C
Circulation; 2004 Sep; 110(13):1819-25. PubMed ID: 15364804
[TBL] [Abstract][Full Text] [Related]
3. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction.
Katada J; Meguro T; Saito H; Ohashi A; Anzai T; Ogawa S; Yoshikawa T
Circulation; 2005 May; 111(17):2157-64. PubMed ID: 15851599
[TBL] [Abstract][Full Text] [Related]
4. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
6. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats.
Lal A; Veinot JP; Leenen FH
Cardiovasc Res; 2004 Dec; 64(3):437-47. PubMed ID: 15537497
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone receptor antagonism in heart failure.
Jennings DL; Kalus JS; O'Dell KM
Pharmacotherapy; 2005 Aug; 25(8):1126-33. PubMed ID: 16207104
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone and cardiovascular remodelling: focus on myocardial failure.
Shieh FK; Kotlyar E; Sam F
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):3-13. PubMed ID: 15136967
[TBL] [Abstract][Full Text] [Related]
9. Expression of procollagen C-proteinase enhancer-1 in the remodeling rat heart is stimulated by aldosterone.
Kessler-Icekson G; Schlesinger H; Freimann S; Kessler E
Int J Biochem Cell Biol; 2006 Mar; 38(3):358-65. PubMed ID: 16300990
[TBL] [Abstract][Full Text] [Related]
10. Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy.
Tan LB; Schlosshan D; Barker D
Int J Cardiol; 2004 Sep; 96(3):321-33. PubMed ID: 15310530
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone-induced vasculopathy.
Struthers AD
Mol Cell Endocrinol; 2004 Mar; 217(1-2):239-41. PubMed ID: 15134823
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone blockade in heart failure.
Struthers AD
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S23-7. PubMed ID: 15526239
[TBL] [Abstract][Full Text] [Related]
13. Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarction.
Greenberg B; Zannad F; Pitt B
Am J Cardiol; 2006 May; 97(10A):34F-40F. PubMed ID: 16698333
[TBL] [Abstract][Full Text] [Related]
14. Neurohormones and heart failure: the importance of aldosterone.
Odedra K; Ferro A
Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
Foronjy RF; Sun J; Lemaitre V; D'Armiento JM
Hypertens Res; 2008 Apr; 31(4):725-35. PubMed ID: 18633185
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of heart failure following myocardial infarction.
Struthers AD
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone blockade in patients with chronic heart failure.
Pitt B
Cardiol Clin; 2008 Feb; 26(1):15-21, v. PubMed ID: 18312902
[TBL] [Abstract][Full Text] [Related]
19. [Effects of aldosterone receptor blocker therapy on cardiac remodeling].
Boccanelli A; Battagliese A
G Ital Nefrol; 2006; 23 Suppl 34():S57-63. PubMed ID: 16633997
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells.
Ambroisine ML; Favre J; Oliviero P; Rodriguez C; Gao J; Thuillez C; Samuel JL; Richard V; Delcayre C
Circulation; 2007 Nov; 116(21):2435-43. PubMed ID: 17984374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
